糖化白蛋白酶法检测的多中心性能评估
该研究首次在多中心评估了酶法糖化白蛋白(GA)检测(quantILab Glycated Albumin assay)在多种临床生化分析仪上的分析性能。结果显示重复性CV为0.9%–1.2%,室内CV为1.2%–1.6%,实验室间相关系数0.996–0.998,线性范围7.6–84.7%,结论为该酶法适合临床使用。
要点
- 酶法GA检测重复性CV为0.9%–1.2%,室内CV为1.2%–1.6%。
- 实验室间相关性好,相关系数0.996–0.998。
- 线性范围确认为7.6%–84.7%,方法适合临床使用。
核心结论
- 该酶法糖化白蛋白检测经多中心评估适合临床使用。
研究设计与样本
- 首次多中心评估酶法GA检测(quantILab Glycated Albumin assay)在Abbott Architect C8000、Beckman Coulter AU 480和680、Roche Cobas C6000、Siemens ADVIA 2400和2400 XPT上的分析性能。
主要发现
- 参与中心的GA检测重复性CV为0.9%–1.2%。
- 室内CV为1.2%–1.6%。
- 实验室间相关性好,相关系数为0.996–0.998。
- 线性范围确认为7.6%–84.7%。
关键数值与推荐
- 重复性CV:0.9%–1.2%。
- 室内CV:1.2%–1.6%。
- 实验室间相关系数:0.996–0.998。
- 线性范围:7.6%–84.7%。
临床怎么用
- 该酶法GA检测可在常用临床生化分析仪上用于血糖控制监测,尤其在HbA1c不可靠时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of glycated albumin (GA) has been proposed as an additional glycemic control marker particularly useful in intermediate-term monitoring and in situation when HbA1c test is not reliable. METHODS: We have performed the first multicenter evaluation of the analytical performance of the enzymatic method quantILab Glycated Albumin assay implemented on the most widely used clinical chemistry analyzers (i.e. Abbott Architect C8000, Beckman Coulter AU 480 and 680, Roche Cobas C6000, Siemens ADVIA 2400 and 2400 XPT). RESULTS: The repeatability of the GA measurement (expressed as CV, %) implemented in the participating centers ranged between 0.9% and 1.2%. The within-laboratory CVs ranged between 1.2% and 1.6%. A good alignment between laboratories was found, with correlation coefficients from 0.996 to 0.998. Linearity was confirmed in the range from 7.6 to 84.7%. CONCLUSION: The new enzymatic method for glycated albumin evaluated by our investigation is suitable for clinical use.
引用
- Paleari R, Bonetti G, Callà C, et al. Multicenter evaluation of an enzymatic method for glycated albumin. Clin Chim Acta. 2017. PMID: 28365449. doi:10.1016/j.cca.2017.03.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。